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SHORT COMMUNICATION

Screening for G6PD Deficiency Among Neonates with Neonatal
Jaundice Admitted to Tertiary Care Center: A Need in Disguise
Kishwer Kumar1, Arjumand Sohaila1, Shiyam Sunder Tikmani1, Iqtidar Ahmed Khan1 and Anila Zafar2

ABSTRACT

This study was conducted to determine the association of Glucose-6-Phosphate Dehydrogenase (G-6-PD) deficiency
among neonates admitted with jaundice at the neonatal intensive care unit, well baby nursery and neonatal step down
nursery of the Aga Khan University Hospital, Karachi, Pakistan, from January to June 2010. A total of 205 neonates
following the selection criteria were included. All selected neonates have their venous blood drawn, saved in EDTA bottle
and sent to laboratory of The Aga Khan University Hospital (AKUH). The laboratory results of whether G-6-PD deficiency
was present or not was recorded in the proforma. G-6-PD was deficient in 19 neonates (9.3%). All neonates were male.
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Glucose-6-Phosphatase Dehydrogenase (G-6-PD)
deficiency inherited as an X-linked recessive disorder, is
notorious due to potentially life-threatening hemolysis
(favism) and severe bilirubin encephalopathy (kernicterus)
in neonates. All babies with G-6-PD deficiency usually
developed hyperbilirubinaemia within the first week of
life. Phototherapy is required by almost all the neonates
with an additional requirement of exchange transfusion
in several.1 If not appropriately treated, Kernicterus is
likely to develop into life-long severe mental retardation.
In Pakistan, most of the new-borns (65%) are delivered
at home.2 If they develop jaundice, parents usually do
not seek medical advice immediately. The usual practice
is to keep the baby at home and treat the jaundice by
exposing the baby to early morning sun-shine or give
glucose water or use spiritual methods etc. These
practices not only increase the risk for severe jaundice
but also its life-long consequences. Various population
based studies have shown a prevalence ranging from 2
to 3.8%.3 There are only few local studies available to
determine the prevalence of G-6-PD deficiency in
Pakistani neonates. This cross sectional study was
carried out at neonatal intensive care unit, well baby and
neonatal step down nursery of the Aga Khan University
Hospital (AKU), from January to June 2010. All admitted
neonates whether born in AKU or outside AKU, having
jaundice with serum bilirubin of 15 mg/dl for term baby
and 12 mg/dl for pre-term with predominant unconjugated
hyperbilirubinaemia, of either gender were enrolled in the
study following the written informed consent. Neonates
with congenital anomalies or conjugated bilirubin more
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than 20% of the total bilirubin or those who had history
of blood or exchange transfusion or received other
therapy (e.g. phenobarbitone or metalloporphyrins etc.)
were excluded from this study. Venous blood sample of 2
- 3 ml was drawn from selected neonates and was sent
to the AKUH laboratory. Enzyme assay for G-6-PD was
carried out on whole blood with EDTA as anticoagulant.
The details of neonates and laboratory results were
recorded in the proforma. The data was entered and
analyzed in SPSS version 20 (SPSS Inc., Chicago, IL,
USA). The categorical variables were presented as
frequencies and percentages; and continuous variables
were reported as mean ± standard deviation. Effect
modifiers like age, weight, gestational age and serum
indirect bilirubin were controlled through stratification to
see the effect of the variables on outcome using chisquare test and p-value of ≤ 0.05 was considered
significant.

The present samples of 205 preterm/term neonates with
indirect hyperbilirubinaemia were included. The average
total serum bilirubin (SBR) was 18.03 ± 13.4 mg/dL with
direct average SBR was 0.54 ± 0.26 mg/dL and the
average indirect SBR was 16.55 ± 2.91 mg/dL. The
results found that the prevalence of glucose-6Phosphate Dehydrogenase (G-6-PD) deficiency was
9.3% i.e. 19 neonates were deficient whereas 186
neonates i.e. 90.7% were not deficient. All of these
neonates were male. Thirty six (17.6%) were preterm
and 169 (82.4%) term infants. The mean age of
neonates at the time of presentation was 4.52 ± 3.042
days (ranging from 2 to 17 days). The mean weight of
enrolled neonates was 2.7 ± 0.375 kg (ranging from 2.0
to 3.6 kg). Stratified analysis of G-6-PG deficiency by
different variables is shown in Table I.
A study with the same objective but with large sample
size was conducted in Saudi Arabia, found the
prevalence of G-6-PD deficiency of 2%.4 Likewise in
Iran, to determine the prevalence of G-6-PD deficiency
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Table I: Stratified analysis of G-6-PG deficiency by different variables.
Variables

Age (days)

0 - 6 days

7 - 28 days

Weight (kg)
< 2.5 kg

Glucose-6-phosphate
dehydrogenase deficiency

p-value

Yes (n=19)

No (n=186)

18 (94.7%)

154 (82.7%)

0.321*

1 (5.2%)

≥ 2.5 kg

10 (52.6%)

124 (66.6%)

62 (33.3%)

0.310**

Term

17 (89.4%)

152 (81.7%)

0.537*

96 (51.6%)

0.220**

Gestational age
Preterm

Serum indirect bilirubin (mg/dl)
< 17.5 mg/dl
≥ 17.5 mg/dl

9 (47.3%)

32 (17.2%)

2 (10.5%)

7 (36.8%)

12 (63.1%)

34 (18.2%)

90 (48.3%)

*p-value calculated by Fisher's exact test; **p-value calculated by Chi-square test.

out of a large sample (1307 males, 1194 females)
screened, 79 neonates were found to have G-6-PD
deficiency. The overall incidence of G-6-PD deficiency
was 3.2%.5 The present study although showed a
prevalence around 9% which is very high as compared
to above mentioned studies.

A study was conducted in Pakistan to detect the
frequency of G-6-PD deficiency in 200 neonates
admitted with jaundice to the neonatal unit, LRH,
Peshawar. There were 145 (72.5%) were males while 55
(27.5%) were females. The results found that 16% (32)
babies were found to be G-6-PD deficient.6 These
results showed a lower prevalence of G-6-PD deficiency
in jaundiced neonates in Karachi. However, this small
difference may be due to differences in sampling and
sample size.
G-6-PD deficiency is a common cause of neonatal
jaundice and has more propensity for male gender.
Babies suffering from G-6-PD deficiency present with
jaundice relatively earlier than the other causes of
neonatal jaundice like ABO/Rh incompatibility and
idiopathic causes. So early characterization of G-6-PD
activity provides an etiological diagnosis for Neonatal
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Jaundice (NJ), as well as the opportunity for the early
institution of the therapy like phototherapy etc. This will
prevent the child from complications of neonatal
jaundice but also long-term consequences i.e. mental
retardation and cerebral palsy. Early detection of this
enzymopathy would be a viable option through mass
screening programs. Several factors needed to be
considered in evaluating the feasibility, need and cost
effectiveness of any neonatal mass screening programs,
prevalence and severity of the disease in target
population, availability of inexpensive and user friendly
screening tests, access to treatment and follow-ups etc.
the authors recommend a large study with more female
neonates to validate these findings as well as other
factors that can act as confounders. There is strong
relationship between G-6-PD deficiency and severe
neonatal jaundice. This provides a very strong rationale
to collect epidemiological data so that treatment,
prevention and management strategies could be
developed, applied and implemented, keeping in view
the local socio-demographic characteristics.
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